Currently, there is no FDA-approved indication for GLP-1 receptor agonists or GIP/GLP-1 dual agonists specifically for lipedema treatment, and high-quality clinical trial evidence remains limited
The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care
If you have more questions about our Metabolic Reset program, reach out to [email protected]
Adam Auton, geneticist at 23andMe, to break down a brand new paper using data from over 27,000 people that identified specific genetic variants linked to how well GLP-1 medications work and how likely someone is to experience side effects
Other Options If you're already under the care of a provider, simply have them contact us, and we'll assist with processing the prescription by phone/fax/eRx
While NAC can help boost internal levels, it still relies on your body's ability to complete the synthesis process